A Bioequivalence Study of Two Different PEG-rhGH Preparations.

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 9, 2024

Primary Completion Date

July 15, 2024

Study Completion Date

August 28, 2024

Conditions

Pediatric Growth Hormone Deficiency (PGHD)

Interventions

DRUG

PEG-rhGH with new preparation (T)

A single subcutaneous injection of PEG-rhGH with new preparation

DRUG

PEG-rhGH with present preparation (R)

A single subcutaneous injection of PEG-rhGH with present preparation

Trial Locations (1)

Chengdu Xinhua Hospital, Chengdu

All Listed Sponsors

lead

Changchun GeneScience Pharmaceutical Co., Ltd.

INDUSTRY

NCT06331026 - A Bioequivalence Study of Two Different PEG-rhGH Preparations. | Biotech Hunter | Biotech Hunter